Sleep-disordered breathing in acute decompensated heart failure.

Area of Science:

• Cardiology
• Pulmonology
• Sleep Medicine

Background:

• Sleep-disordered breathing (SDB) is highly prevalent in chronic heart failure (HF) patients.
• SDB, encompassing obstructive sleep apnea (OSA) and central sleep apnea (CSA), is often undiagnosed in HF.
• Untreated SDB can exacerbate HF decompensation and hinder recovery.

Purpose of the Study:

• To review the impact of SDB on heart failure.
• To discuss the prognostic implications of OSA and CSA in HF.
• To evaluate the therapeutic benefits of treating SDB in HF patients.

Main Methods:

• Literature review and synthesis of existing research on SDB and HF.
• Analysis of epidemiological data and clinical trial outcomes.
• Discussion of pathophysiological mechanisms linking SDB to HF progression.

Main Results:

• Untreated OSA increases the risk of developing HF and worsens prognosis in HF patients.
• OSA treatment in HF patients is associated with reduced cardiovascular morbidity and mortality.
• CSA presence in HF is linked to increased mortality, with potential benefits from continuous positive airway pressure (CPAP) therapy.

Conclusions:

• SDB is a significant comorbidity in HF that requires recognition and management.
• Effective treatment of OSA and CSA can potentially improve cardiovascular outcomes and reduce mortality in HF patients.
• Further research into SDB management strategies in HF is warranted.